A prospective study reported a poor prognosis in patients with HER2-overexpressing GC [18], and the results of a multicenter study in Japan that evaluated the relationship between HER2 status and prognosis in 1148 GC patients also showed that HER2 overexpression was associated with prognosis [19]. Here, ERBB2 is linked to gastric cancer.